Cytek Biosciences Net Debt Growth & History (CTKB)

Cytek Biosciences's net debt was −$73.9M for fiscal 2025.

View full Cytek Biosciences company overview

Cytek Biosciences annual net debt history

Cytek Biosciences annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-12-31−$73.9M$13.5M
20242024-12-31−$87.4M$68.0M
20232023-12-31−$155.4M$126.0M
20222022-12-31−$281.4M$83.3M
20212021-12-31−$364.6M

Cytek Biosciences net debt trends

Between the periods ended 2021-12-31 and 2025-12-31, Cytek Biosciences's net debt increased from −$364.6M to −$73.9M, a change of $290.7M. The latest reported quarter, Q2 2026, shows −$57.1M.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Cytek Biosciences source filings ↗

Community posts

It’s quiet here.

No posts about CTKB yet. Start the conversation.

Write the first post